Sign Out
Adults: pms-ONDANSETRON (ondansetron hydrochloride) is indicated for:
the prevention of nausea and vomiting associated with emetogenic chemotherapy, including high dose cisplatin, and radiotherapy; the prevention and treatment of post-operative nausea and vomiting.
Pediatrics (4 to 18 years of age): Post-Chemotherapy Induced Nausea and Vomiting: Ondansetron hydrochloride was effective and well-tolerated when given to children 4 to 12 years of age (see Dosage & Administration). pms-ONDANSETRON is not indicated for the treatment of children 3 years of age or younger.
Post-Radiotherapy Induced Nausea and Vomiting: pms-ONDANSETRON is not indicated for use in any age group of this population.
Post-Operative Nausea and Vomiting: pms-ONDANSETRON is not indicated for use in any age group of this population.
Geriatrics (> 65 years of age): Post-Chemotherapy and Radiotherapy Induced Nausea and Vomiting: Efficacy and tolerance of ondansetron hydrochloride were similar to that observed in younger adults (see Dosage & Administration).
Post-Operative Nausea and Vomiting: Clinical experience in the use of ondansetron hydrochloride in the prevention and treatment of post-operative nausea and vomiting is limited and is not indicated for use in this population.
